Discovery and Synthesis of a Phosphoramidate Prodrug of a Pyrrolo(2,1-f][triazin-4-amino] Adenine C-Nucleoside (GS-5734) for the Treatment of Ebola and Emerging Viruses

被引:504
作者
Siegel, Dustin [1 ]
Hui, Hon C. [1 ]
Doerffler, Edward [1 ]
Clarke, Michael O. [1 ]
Chun, Kwon [1 ]
Zhang, Lijun [1 ]
Neville, Sean [1 ]
Carra, Ernest [1 ]
Lew, Willard [1 ]
Ross, Bruce [1 ]
Wang, Queenie [1 ]
Wolfe, Lydia [1 ]
Jordan, Robert [1 ]
Soloveva, Veronica [2 ]
Knox, John [1 ]
Perry, Jason [1 ]
Perron, Michel [1 ]
Stray, Kirsten M. [1 ]
Barauskas, Ona [1 ]
Feng, Joy Y. [1 ]
Xu, Yili [1 ]
Lee, Gary [1 ]
Rheingold, Arnold L. [3 ]
Ray, Adrian S. [1 ]
Bannister, Roy [1 ]
Strickley, Robert [1 ]
Swaminathan, Swami [1 ]
Lee, William A. [1 ]
Bavari, Sina [1 ,2 ]
Cihlar, Tomas [1 ]
Lo, Michael K. [4 ]
Warren, Travis K. [2 ]
Mackman, Richard L. [1 ]
机构
[1] Inc, Gilead Sci, Foster City, CA 94404 USA
[2] United States Army Med Res Inst Infect Dis USAMR, Frederick, MD 21702 USA
[3] Univ Calif San Diego, San Diego, CA 92093 USA
[4] Centers Dis Control & Prevent, Atlanta, GA 30333 USA
关键词
ANTIVIRAL ACTIVITY; MITOCHONDRIAL RNA; T-705; FAVIPIRAVIR; 4-AZA-7,9-DIDEAZAADENOSINE; TRANSMISSION; REPLICATION; POLYMERASE; INHIBITOR; INFECTION; EFFICACY;
D O I
10.1021/acs.jmedchem.6b01594
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The recent Ebola virus (EBOV) outbreak in West Africa was the largest recorded in history with over 28,000 cases, resulting in >11,000 deaths including >500 healthcare workers. A focused screening and lead optimization effort identified 4b (GS-5734) with anti-EBOV EC50 = 86 nM in macrophages as the clinical candidate. Structure activity relationships established that the l'-CN group and C-linked nucleobase were critical for optimal anti-EBOV potency and selectivity against host polymerases. A robust diastereoselective synthesis provided sufficient quantities of 4b to enable preclinical efficacy in a non-human-primate EBOV challenge model. Once-daily 10 mg/kg iv treatment on days 3-14 postinfection had a significant effect on viremia and mortality, resulting in 100% survival of infected treated animals [Nature 2016, 531, 381-385]. A phase 2 study (PREVAIL IV) is currently enrolling and will evaluate the effect of 4b on viral shedding from sanctuary sites in EBOV survivors.
引用
收藏
页码:1648 / 1661
页数:14
相关论文
共 44 条
[1]  
[Anonymous], 2016, Ebola Situation Report
[2]   Structural basis for RNA replication by the hepatitis C virus polymerase [J].
Appleby, Todd C. ;
Perry, Jason K. ;
Murakami, Eisuke ;
Barauskas, Ona ;
Feng, Joy ;
Cho, Aesop ;
Fox, David, III ;
Wetmore, Diana R. ;
McGrath, Mary E. ;
Ray, Adrian S. ;
Sofia, Michael J. ;
Swaminathan, S. ;
Edwards, Thomas E. .
SCIENCE, 2015, 347 (6223) :771-775
[3]   Species difference of esterase expression and hydrolase activity in plasma [J].
Bahar, Fatma Goksin ;
Ohura, Kayoko ;
Ogihara, Takuo ;
Imai, Teruko .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2012, 101 (10) :3979-3988
[4]  
Butler T., 2010, U.S. Patent, Patent No. 20100459508
[5]  
Butler T., 2009, Patent No. [US 2009041447, 2009041447]
[6]   Discovery of the First C-Nucleoside HCV Polymerase Inhibitor (GS-6620) with Demonstrated Antiviral Response in HCV Infected Patients [J].
Cho, Aesop ;
Zhang, Lijun ;
Xu, Jie ;
Lee, Rick ;
Butler, Thomas ;
Metobo, Sammy ;
Aktoudianakis, Vangelis ;
Lew, Willard ;
Ye, Hong ;
Clarke, Michael ;
Doerffler, Edward ;
Byun, Daniel ;
Wang, Ting ;
Babusis, Darius ;
Carey, Anne C. ;
German, Polina ;
Sauer, Dorothea ;
Zhong, Weidong ;
Rossi, Stephen ;
Fenaux, Martijn ;
McHutchison, John G. ;
Perry, Jason ;
Feng, Joy ;
Ray, Adrian S. ;
Kim, Choung U. .
JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (05) :1812-1825
[7]   Synthesis and antiviral activity of a series of 1′-substituted 4-aza-7,9-dideazaadenosine C-nucleosides [J].
Cho, Aesop ;
Saunders, Oliver L. ;
Butler, Thomas ;
Zhang, Lijun ;
Xu, Jie ;
Vela, Jennifer E. ;
Feng, Joy Y. ;
Ray, Adrian S. ;
Kim, Choung U. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (08) :2705-2707
[8]   Discovery of β-D-2′-deoxy-2′-α-fluoro-4′-α-cyano-5-aza-7,9-dideaza adenosine as a potent nucleoside inhibitor of respiratory syncytial virus with excellent selectivity over mitochondrial RNA and DNA polymerases [J].
Clarke, Michael O. ;
Mackman, Richard ;
Byun, Daniel ;
Hui, Hon ;
Barauskas, Ona ;
Birkus, Gabriel ;
Chun, Byoung-Kwon ;
Doerffler, Edward ;
Feng, Joy ;
Karki, Kapil ;
Lee, Gary ;
Perron, Michel ;
Siegel, Dustin ;
Swaminathan, Swami ;
Lee, William .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (12) :2484-2487
[9]   Role of Mitochondrial RNA Polymerase in the Toxicity of Nucleotide Inhibitors of Hepatitis C Virus [J].
Feng, Joy Y. ;
Xu, Yili ;
Barauskas, Ona ;
Perry, Jason K. ;
Ahmadyar, Shekeba ;
Stepan, George ;
Yu, Helen ;
Babusis, Darius ;
Park, Yeojin ;
McCutcheon, Krista ;
Perron, Michel ;
Schultz, Brian E. ;
Sakowicz, Roman ;
Ray, Adrian S. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (02) :806-817
[10]   Inhibition of Hepatitis C Virus Replication by GS-6620, a Potent C-Nucleoside Monophosphate Prodrug [J].
Feng, Joy Y. ;
Cheng, Guofeng ;
Perry, Jason ;
Barauskas, Ona ;
Xu, Yili ;
Fenaux, Martijn ;
Eng, Stacey ;
Tirunagari, Neeraj ;
Peng, Betty ;
Yu, Mei ;
Tian, Yang ;
Lee, Yu-Jen ;
Stepan, George ;
Lagpacan, Leanna L. ;
Jin, Debi ;
Hung, Magdeleine ;
Ku, Karin S. ;
Han, Bin ;
Kitrinos, Kathryn ;
Perron, Michel ;
Birkus, Gabriel ;
Wong, Kelly A. ;
Zhong, Weidong ;
Kim, Choung U. ;
Carey, Anne ;
Cho, Aesop ;
Ray, Adrian S. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (04) :1930-1942